Landmark advance as malaria vaccine first to hit WHO goal
Issued on:
23/04/2021 - 18:58 Malaria killed at least four times as many more people in Africa last year as Covid did, Professor Adrian Hill said Olympia DE MAISMONT AFP/File 3 min
London (AFP)
A new malaria vaccine has proven 77 percent effective in trials on infants, British researchers said Friday, in what could prove to be a potential game-changer against the deadly mosquito-borne disease.
In a clinical trial in Burkina Faso, the Matrix-M vaccine developed by the University of Oxford s Jenner Institute was found to be 77 percent effective after 450 infants inoculated in 2019 were followed up for a year, the Oxford researchers said in a statement.
New Malaria Vaccine May Be The Key to Finally Controlling The Disease
sciencealert.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencealert.com Daily Mail and Mail on Sunday newspapers.
Landmark advance as malaria vaccine first to hit WHO goal
news24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news24.com Daily Mail and Mail on Sunday newspapers.
I’m grateful to
CEPI for bringing us together and to Chatham House for hosting this essential and timely conversation.
It matters because there will be more vaccines produced in the next 10 years than ever in human history.
Our efforts on COVID vaccine supply and manufacturing here in the UK are well progressed:
over 22 million have received their first dose – two-fifths of our adult population
we’re on course to offer a first dose to the rest of the adult population by the end of July; and
our second doses are well underway
At the same time-at the global level-we’re only just getting started, with much of the world still unvaccinated against COVID-19.